硫福拉通过激活PI3K/AKT通路来减轻甲基胺诱导的神经毒性
Shuyue Li1,2,3, Jinlong Zhang2, Xuezhi Li3
1Department of Forensic Science, School of Basic Medical Science, Xinjiang Medical University, Urumqi, Xinjiang, China.
Journal of biochemical and molecular toxicology
|March 9, 2026
概括
硫法 (SFN) 通过激活PI3K/AKT通路来保护甲基胺 (METH) 神经毒性. 这种天然化合物抑制了细胞亡,为METH诱导的神经元损伤提供了潜在的治疗益处.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 生物化学 生化学
背景情况:
- 滥用甲基胺 (METH) 导致显著的神经毒性,主要是通过氧化应激和亡.
- 甲 (SFN) 是一种来自十字花蔬菜的化合物,具有神经保护性,但其对METH诱导损伤的有效性尚未得到充分证实.
研究的目的:
- 研究SFN对METH诱导的神经毒性的神经保护作用.
- 阐明潜在的分子机制,重点关注PI3K/AKT信号通路和亡.
主要方法:
- 综合网络药理学,分子对接,体外 (HT22细胞) 和体内 (老鼠模型) 实验.
- 评估了细胞活力,细胞亡标志物 (Bcl-2/BAX比率,酶-3,TUNEL) 和蛋白质表达 (p-PI3K,p-AKT).
主要成果:
- SFN治疗改善了细胞活力,并减少了HT22细胞中METH诱导的亡.
- 在接受METH治疗的小鼠模型中,SFN的使用改善了海马的损伤和亡.
- SFN的保护作用与PI3K/AKT通路的激活有关,由增加的酸化证明.
结论:
- 通过PI3K/AKT通路抑制线粒体依赖性亡,SFN有效地减轻METH诱导的神经毒性.
- SFN显示出作为一种治疗药物的潜力,用于管理与METH相关的神经元损伤.
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
6.1K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
6.1K
Interactions Between Signaling Pathways
7.6K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.6K
The JAK-STAT Signaling Pathway
13.5K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
13.5K
mTOR Signaling and Cancer Progression
5.0K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
5.0K
MAPK Signaling Cascades
8.9K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
8.9K
Phase II Reactions: Methylation Reactions
837
Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
837

